Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 75

Results For "marketing"

816 News Found

Gland Pharma receives tentative nod for Sugammadex injection
Drug Approval | October 09, 2021

Gland Pharma receives tentative nod for Sugammadex injection

The injection is used to reverse the effects of the muscle relaxants given to patients during surgery


Paediatric healthcare platform Health Basix raises seed fund
Startup | October 06, 2021

Paediatric healthcare platform Health Basix raises seed fund

The company will use the capital for building its team, product development, marketing, and setting up in-school clinics to deliver connected health to one million families


Mawi DNA announce partnership with FUJIFILM
Medical Device | October 05, 2021

Mawi DNA announce partnership with FUJIFILM

FUJIFILM will distribute iSWAB bio sampling technologies in Japan


Natco announces launch of 10 mg Everolimus in the US
Drug Approval | October 01, 2021

Natco announces launch of 10 mg Everolimus in the US

According to industry sales data, the 10mg strength of Afinitor generated annual sales of US $ 392 million during the twelve months ending July 2021


Tavneos (avacopan) approved for ANCA associated vasculitis in Japan
Drug Approval | September 28, 2021

Tavneos (avacopan) approved for ANCA associated vasculitis in Japan

It is the first orally administered therapy for the treatment of two types of ANCA-associated vasculitis approved in Japan


Cadila Healthcare signs agreement with Shilpa Medicare for production of ZyCoV-D
News | September 26, 2021

Cadila Healthcare signs agreement with Shilpa Medicare for production of ZyCoV-D

ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the Covid-19 virus


Aurobindo subsidiary submits MAA for oncology biosimilar
Biotech | September 23, 2021

Aurobindo subsidiary submits MAA for oncology biosimilar

CuraTeQ Biologics is on track for filing a second oncology biosimilar


HUTCHMED initiates a Japan bridging study to Support Surufatinib
Biotech | September 21, 2021

HUTCHMED initiates a Japan bridging study to Support Surufatinib

Surufatinib is the third potential new medicine discovered by the company to enter into clinical development in Japan


Argenta acquires Klifovet to expand global footprint in animal health
Biotech | September 17, 2021

Argenta acquires Klifovet to expand global footprint in animal health

Klifovet’s client base comprises the world’s top animal health and nutrition companies as well as many promising startups


Lancet study confirms Johnson & Johnson Ebola vaccine safe
Drug Approval | September 16, 2021

Lancet study confirms Johnson & Johnson Ebola vaccine safe

Data show the vaccine regimen induced neutralising antibody responses in nearly all participating adults and children 21 days after the second dose. Adults receiving booster shots two years after the initial vaccination regimen showed strong immune responses